LYEL
Lyell Immunopharma Inc
NASDAQ: LYEL · HEALTHCARE · BIOTECHNOLOGY
$19.73
-4.22% today
Updated 2026-04-30
Market cap
$527.78M
P/E ratio
—
P/S ratio
14,660.60x
EPS (TTM)
$-16.06
Dividend yield
—
52W range
$8 – $45
Volume
0.1M
Lyell Immunopharma Inc (LYEL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |